Contact Supplier

Contact Supplier

To get in touch with Evercyte GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .

    Evercyte adds telomerized perinatal cells to immortalized range

    products-servicesEvercyte GmbH
    October 8th 2024

    Evercyte has added a range of telomerized perinatal cells that can be grown without limitations in vitro while maintaining cell type-specific markers and functions to its portfolio of immortalized cell lines.

    These newly developed mesenchymal stromal cells (MSCs) are derived from different regions of the placenta and epithelial cells and provide valuable and standardizable in vitro models for studies such as those into the barrier function of the placenta or to perform toxicity assays.

    Perinatal cell range

    The four new additions are:

    • P-EP/SVTERT344 – Amniotic Epithelial Cells
    • P-MSC/TERT308 – Placental Amnion MSCs
    • CP-MSC/TERT308 – Placental Chorionic Plate MSCs
    • RA-MSC/TERT308 – Reflected Amnion MSCs

    As with Evercyte’s other telomerized cell lines, these human perinatal cells and MSCs can be grown without limitations while maintaining expression of cell type-specific markers and function.

    MSC-derived perinatal cells can be used to produce clinical-grade EVs. The cells were established under xeno-free conditions, with full documentation of any manipulation step and therefore can be transferred to a GMP facility to generate a master cell bank that can be used to produce clinical-grade extracellular vesicles.

    Telomerized cell advantages  

    Primary cells maintain a phenotype like the corresponding cells in vivo. However, their application is limited due to their finite life span. Tumor cells, on the other hand, can be grown indefinitely but lose essential characteristics. These disadvantages of normal and tumor cell lines lead to the drawback that most in vitro bioassays cannot be reproduced and standardized.

    To circumvent these limitations, Evercyte has focused on the establishment of telomerized cell lines that can be grown without growth arrest while maintaining a phenotype that resembles that of the corresponding primary/normal cells.

    This is achieved by ectopic expression of the catalytic subunit of human telomerase and/or cell cycle regulators in primary cells followed by a detailed characterization of the cellular phenotype.

    Resources

    Click on P-EP/SVTERT344 Amniotic Epithelial Cells for product information.
    Click on P-MSC/TERT308 Placental Amnion MSCs for product information.
    Click on CP-MSC/TERT308 –  Placental Chorionic Plate MSCs for product information.
    Click on RA-MSC/TERT308 – Reflected Amnion MSCs for product information.
    Click on Evercyte bodily fluids and tissues cell line portfolio to learn more.

    Evercyte adds telomerized perinatal cells to immortalized range

    Image created with Biorender

    Evercyte GmbH

    Contact Information
    Address: Leberstrasse 20, 1110 Vienna, Austria
    Telephone No: +43 699 10 709 401
    Email Address: [email protected]

    Contact Evercyte GmbH

    Simply fill out the form below to contact Evercyte GmbH now.

    Send Evercyte GmbH a Message